These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36754326)

  • 21. Biodegradability and toxicity of pharmaceuticals in biological wastewater treatment plants.
    Carucci A; Cappai G; Piredda M
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2006; 41(9):1831-42. PubMed ID: 16849129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Municipal wastewater treatment targeting pharmaceuticals by a pilot-scale hybrid attached biofilm and activated sludge system (Hybas™).
    Tang K; Ooi GTH; Torresi E; Kaarsholm KMS; Hambly A; Sundmark K; Lindholst S; Sund C; Kragelund C; Christensson M; Bester K; Andersen HR
    Chemosphere; 2020 Nov; 259():127397. PubMed ID: 32599380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cometabolic biotransformation and impacts of the anti-inflammatory drug diclofenac on activated sludge microbial communities.
    Nguyen LN; Nghiem LD; Pramanik BK; Oh S
    Sci Total Environ; 2019 Mar; 657():739-745. PubMed ID: 30677939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
    Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
    Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Various species of Basidiomycota fungi reveal different abilities to degrade pharmaceuticals and also different pathways of degradation.
    Kózka B; Sośnicka A; Nałęcz-Jawecki G; Drobniewska A; Turło J; Giebułtowicz J
    Chemosphere; 2023 Oct; 338():139481. PubMed ID: 37454990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suspended biofilm carrier and activated sludge removal of acidic pharmaceuticals.
    Falås P; Baillon-Dhumez A; Andersen HR; Ledin A; la Cour Jansen J
    Water Res; 2012 Mar; 46(4):1167-75. PubMed ID: 22209263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes.
    Gao P; Ding Y; Li H; Xagoraraki I
    Chemosphere; 2012 Jun; 88(1):17-24. PubMed ID: 22494528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioremediation of bezafibrate and paroxetine by microorganisms from estuarine sediment and activated sludge of an associated wastewater treatment plant.
    Duarte P; Almeida CMR; Fernandes JP; Morais D; Lino M; Gomes CR; Carvalho MF; Mucha AP
    Sci Total Environ; 2019 Mar; 655():796-806. PubMed ID: 30577142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An activated sludge modeling framework for xenobiotic trace chemicals (ASM-X): assessment of diclofenac and carbamazepine.
    Plósz BG; Langford KH; Thomas KV
    Biotechnol Bioeng; 2012 Nov; 109(11):2757-69. PubMed ID: 22565415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abiotic and biotic processes of diclofenac in enriched nitrifying sludge: Kinetics, transformation products and reactions.
    Wu G; Geng J; Li S; Li J; Fu Y; Xu K; Ren H; Zhang X
    Sci Total Environ; 2019 Sep; 683():80-88. PubMed ID: 31136967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of emerging micropollutants removal by aerobic activated sludge of large laboratory-scale membrane bioreactors and sequencing batch reactors under low-temperature conditions.
    Kruglova A; Kråkström M; Riska M; Mikola A; Rantanen P; Vahala R; Kronberg L
    Bioresour Technol; 2016 Aug; 214():81-88. PubMed ID: 27128192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active heterotrophic biomass and sludge retention time (SRT) as determining factors for biodegradation kinetics of pharmaceuticals in activated sludge.
    Majewsky M; Gallé T; Yargeau V; Fischer K
    Bioresour Technol; 2011 Aug; 102(16):7415-21. PubMed ID: 21652206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate of pharmaceuticals in full-scale source separated sanitation system.
    Butkovskyi A; Hernandez Leal L; Rijnaarts HH; Zeeman G
    Water Res; 2015 Nov; 85():384-92. PubMed ID: 26364222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are pharmaceuticals removal and membrane fouling in electromembrane bioreactor affected by current density?
    Borea L; Ensano BMB; Hasan SW; Balakrishnan M; Belgiorno V; de Luna MDG; Ballesteros FC; Naddeo V
    Sci Total Environ; 2019 Nov; 692():732-740. PubMed ID: 31539981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
    Suárez S; Ramil M; Omil F; Lema JM
    Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of pharmaceuticals from municipal wastewaters at laboratory scale by treatment with activated sludge and biostimulation.
    Muter O; P Erkons I; Selga T; Berzins A; Gudra D; Radovica-Spalvina I; Fridmanis D; Bartkevics V
    Sci Total Environ; 2017 Apr; 584-585():402-413. PubMed ID: 28126281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linking microbial diversity and population dynamics to the removal efficiency of pharmaceutically active compounds (PhACs) in an anaerobic/anoxic/aerobic (A
    Gallardo-Altamirano MJ; Maza-Márquez P; Montemurro N; Rodelas B; Osorio F; Pozo C
    Chemosphere; 2019 Oct; 233():828-842. PubMed ID: 31200141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of selected pharmaceutically active compounds on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations.
    Wang S; Gunsch CK
    Water Res; 2011 May; 45(11):3398-406. PubMed ID: 21529885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of pharmaceutical active compounds in wastewater by constructed wetlands: Performance and mechanisms.
    Zhang H; Wang XC; Zheng Y; Dzakpasu M
    J Environ Manage; 2023 Jan; 325(Pt A):116478. PubMed ID: 36272291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.